Europe must not abandon the quest for an effective HIV vaccine
On this HIV Vaccine Awareness Day, IAS – the International AIDS Society– calls for the re-engagement of all stakeholders, especially in Europe, in funding HIV vaccine research and development (R&D). After more than 40 years since HIV was discovered, there have been breakthroughs in curbing acquisition through pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART). However,…